Promyelocytic leukemia retinoid signaling targets regulate apoptosis, tissue factor and thrombomodulin expression

Haematologica

Volumn 89, Issue 3, 2004, Pages 286-295

  López Pedrera, Chary ^a   Barbarroja, Nuria ^a   Buendía, Paula ^a   Torres, Antonio ^a   Dorado, Gabriel ^b   Velasco, Francisco ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Apoptosis; ERK MAPK kinases; Procoagulant activities; Promyelocytic leukemia; Retinoids

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; TAMIBAROTENE; THROMBOMODULIN; THROMBOPLASTIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GRANULOCYTE; HUMAN; HUMAN CELL; MORPHOGENESIS; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; BENZOATES; CELL DIFFERENTIATION; CELL LINE, TUMOR; FLAVONOIDS; GENE EXPRESSION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; RETINOIDS; TETRAHYDRONAPHTHALENES; THROMBOMODULIN; THROMBOPLASTIN;

EID: 2942709474     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dragnev KH, Rigas JR, Dmitrovsky E. The retinoids and cancer prevention mechanism. Oncologist 2000;5:361-8.
2. Hansen LS, Sigman CC, Andreola F, Ross SA, Kelloff GJ, DeLuca LM. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;21:1271-9.
3. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, editors. The Retinoids: Biology, Chemistry and Medicine. New York, NY, USA; Raven Press: 1994. p. 319-50.
4. Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, et al. Treatment with a new synthetic retinoid, AM80 of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 1997;90:967-73.
5. Shibakura M, Koyama R, Saito T, Shudo K, Miyasaka N, Kamiyama R, et al. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells. Blood 1997;90:1545-51.
6. Gianni M, de The H. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARα protein and the PML retargeting on PML-nuclear bodies. Leukemia 1999;13:739-49.
7. Ponzanelli I, Gianni M, Giavazzi R, Garofalo A, Nicoletti I, Reichert U, et al. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid. Blood 2000;95:2672-82.
8. Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D, et al. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest 2001;108:851-9.
9. Miranda MB, McGuire TF, Johnson DE. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 2002;16:683-92.
10. Surdo PL, Bottomley MJ, Arcaro A, Siegal G, Panayotou G, Sankar A, et al. Structural and biochemical elevation of the interaction of the phosphatidylinositoi-3-kinase p85 alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates. J Biol Chem 1999;274:15678-85.
11. Vanhaesebroek B, Leevers SJ, Panayotou G. Waterfield MD. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 1997;22:267-72.
12. Leopoldt D, Hanck T, Exner T, Haier U, Wetzker R, Nuruberg B. Gβγ stimulates phosphoinositide 3-kinase γ by direct interaction with two domains of the catalytic p110 subunit. J Biol Chem 1998;273:7024-9.
13. Ho LK, Liu D, Rozycka M, Brown Ra, Fry MJ. Identification of four novel human phosphoinositide 3-kinases defines a multi-isoform subfamily. Biochem Biophys Res Commun 1997;235:130-7.
14. Von Gise A, Lorenz P, Wellbrock C, Hemmings B, Brerberich-Siebelt F, Rapp UR, et al. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals. Mol Cell Biol 2001;21:2324-36.
15. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethyl sulfoxide. J Exp Med 1979;149:969-75.
16. López-Pedrera Ch, Dobado-Berrios PM, Ros R, Torres A, Garcia-Navarro S, Jardi M, et al. Signal transduction pathways underlying the expression of tissue factor and thrombomodulin in promyelocytic cells induced to differentiate by retinoid acid and dibutiryl cAMP. Thromb Haemost 2001;85:1031-6.
17. Stoyanova S, Bulgarelli LG, Kirsch C, Hanck T, Klinger R, Wetzker R, et al. Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase γ. Structure-activity analysis and interactions with wortmannin. Biochem J 1997;324:489-95.
18. Dobado-Berrios PM, López-Pedrera Ch, Velasco F, Aguirre MA, Torres A, Cuadrado MJ. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost 1999;82:1578-82.
19. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998;281:1674-7
20. Fukuchi K, Watanabe H, Tomoyasu S, Ichimura S, Tatsumi K, Gomi K. Phosphatidylinositol 3-kinase inhibitors. Wortmannin or LY 294002 inhibited accumulation of p21 protein after γ-irradiation by stabilization of the protein. Biochim Biophys Acta 2000;1496:207-20.
21. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995;270:27489-94.
22. Towatari M, Lida H, Tanimoto M, Iwata H, Hamaguchi M, Saito H. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 1997;11:479-84.
23. Lopez IM, Crespo P, Pellici PG, Gutkind JS, Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinaseg. Science 1997;275:394-7.
24. Baier R, Bondeva T, Klinger R, Bondev A, Wetzker R. Retinoic acid induces selective expression of phosphoinositide 3-kinase γ in myelomonocytic U937 cells. Cell Growth Differ 1999;10:447-56.
25. McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, et al. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells. Cancer Detect Prev 2001;25:375-93.
26. Blum S, Issbrüker K, Willuweit A, Hehlgans S, Lucerna M, Mechtcheriakova D, et al. An inhibitory role of the phosphatidylinositol 3-kinase-signalling pathway in vascular endothelial growth factor-induced tissue factor expression. J Biol Chem 2001;276:33428-34.
27. Gudas L. Retinoids and vertebrae development. J Biol Chem 1994;269:15399-402.
28. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr Rev 1993;14:651-8.
29. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 2003;5:647-54.
30. Zhao S, Konopleva M, Cabreira-Hansen M, Xie Z, Hu W, Milella M, Estrov Z, Mills GB, Andreeff M. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia 2003 (in press).
31. Hemmings BA. Akt signaling: linking membrane events to life and death decisions. Science 1997;275:628-30.
32. Seimiya H, Tsuruo T. Functional involvement of PTP-U2L in apoptosis subsequent to terminal differentiation of monoblastoid leukemia cells. J Biol Chem 1998;273:21187-93.